WEBULL
WebtradeDownload

Fluidra (BME:FDR) Stock Faces Debt Questions After Q3 Earnings

Simply Wall St · 2d ago

Fluidra just reported Q3 2026 and the stock closed today at €18.70, only modestly ahead over both one week and one month. On the surface that calm finish looks at odds with a quarter built on a 24.1% year to date adjusted EBITDA margin and a net debt to adjusted EBITDA ratio around 2.2x, which keeps leverage in focus.

What traders treated as a routine session was really a sentiment tug of war. Short term price action stayed muted while the earnings print quietly reminded investors that balance sheet strain and valuation are still doing most of the work in shaping the story.

Love Fluidra’s 24.1% adjusted EBITDA margin but uneasy about that 2.2x net debt load doing the heavy lifting? Check out our list of solid balance sheet and fundamentals stocks (202 results).

Q3 2026 Earnings Summary

  • Revenue (Q3 2026 vs. Q3 2025): €549.976m vs. €478.284m (up approximately 15.0%)
  • Net Income (Excl. Extra Items, Q3 2026 vs. Q3 2025): €27.823m vs. €27.470m (broadly stable, up approximately 1.3%)
  • Basic EPS (Q3 2026 vs. Q2 2026): €0.146712 vs. €0.422692 (down approximately 65.3% quarter on quarter)
  • Adjusted EBITDA Margin (YTD 2026): 24.1% (management reference point for profitability and leverage, with net debt to adjusted EBITDA around 2.2x)

Earnings only tell part of the story, and investors who care about what they are really paying for often put more weight on the cash moving through a business than on a single quarter's profit line.

When you line up Fluidra's cash generation against its current share price, the platform's cash flow model suggests the stock could be a hefty 32% undervalued.

BME:FDR Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026
BME:FDR Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026

Fluidra’s Efficiency Ambition Meets Early Execution

Fluidra’s bullish story leans heavily on the idea that cost work and plant moves will reset profitability, not just protect it.

"Manufacturing footprint optimization, including a new cost competitive facility in Tangiers and site consolidation in North America and China, together with an efficiency plan and head count reductions, targets a lower fixed cost run rate that can support EBITDA margin expansion and stronger free cash flow."

Q3 and nine month figures show this ambition starting to show up in the numbers. Adjusted EBITDA margin sits at 24.1% year to date with €23m efficiency savings and a roughly 30 bps improvement in OpEx over sales, even while free cash flow remains modest at €12m as footprint changes and restructuring flow through cash.

One Narrative disagrees with today's price. → See where this Narrative says Fluidra should trade.

Fluidra Bear Case: Charges And Projects Still Bite

Fluidra bears focus on the risk that rising costs and stop start projects blunt earnings quality over time.

"Ongoing investment in digital tools like PoolTrackr and upcoming products such as Jandy Edge, along with R&D for smart automation and robotics, adds cost that needs to be absorbed. If adoption lags or upselling falls short, then operating expenses could run ahead of gross profit and compress net margins."

Q3 highlights this concern. Efficiency savings reached €23m and adjusted EBITDA margin held at 24.1%. However, restructuring and stock based compensation climbed to €45m year to date and free cash flow stayed modest at €12m. Commercial sales also declined 4% year to date, so higher project volatility is still in the numbers.

Hunt For Mispriced Earnings Stories

Fluidra just showed how a solid operating update can sit alongside a muted share price. The real opportunity is spotting stocks that could be undervalued before expectations change.

  • Company 1 - 47% below our estimate - uses a growing pipeline of new leisure centres and pricing tools to capture more revenue per visitor.
  • Company 2 - 27% below our estimate - shifts its probiotic mix toward adult and oral health products that distributors prioritise over pediatric lines.
  • Company 3 - 34% below our estimate - extends a value added IT platform into larger AI heavy projects by integrating acquired service providers and established clients.

That is three of the list. See every one of the 201 undervalued companies on it →